Postoperative Atrial Fibrillation after Minimally Invasive Direct Coronary Artery Bypass: A Single-Center, 5-Year Follow-Up Study
POAF after MIDCAB
DOI:
https://doi.org/10.1532/hsf.3621Keywords:
minimally invasive direct coronary artery bypass, postoperative atrial fibrillation, off-pump, predictors, complicationsAbstract
Objective: To evaluate the risk factors and explore the mid-term outcomes of postoperative atrial fibrillation (POAF) after minimally invasive direct coronary artery bypass (MIDCAB).
Methods: A total of 165 patients, who underwent isolated MIDCAB from 2012 to 2015, were enrolled in the study and retrospectively reviewed. Patients with preoperative arrhythmia, concomitant surgical procedures were excluded. All patients were continuously monitored for POAF until discharge, and two groups were formed: the non-POAF group (140 patients, 71.4% men, mean age 58.83±10.3 years) and the POAF group (25 patients, 84.0% men, mean age 64.52±9.0 years). Early and mid-term outcomes were evaluated, perioperative factors associated with POAF were analyzed with a binary logistic regression model, and the relationship between POAF and major adverse cardiac event (MACE) was analyzed with Cox regression model.
Results: The incidence of POAF in this study was 15.15%. Patients in the POAF group had a significant higher risk of re-entry to ICU (2 cases: 2 cases=8.0%: 1.4%, P = 0.049), renal failure (2 cases: 1 case=8.0%: 0.7%, P = 0.018), and death (1 case: 0 case=4.0%: 0%, P = 0.018). Binary logistic regression showed gender (male), age were independent risk factors of POAF (P = 0.038, 95% confidence interval 1.082-16.286; P = 0.011, 95% confidence interval 1.015-1.117, respectively), preoperative ACEI or ARB usage was a protective factor of POAF (P = 0.010, 95% confidence interval 0.113-0.748). With a 5-year follow up, the overall MACE rate showed no statistical difference between the two groups (P = 0.067).
Conclusions: POAF after MIDCAB was related to postoperative morbidities, such as re-entry to ICU, renal failure, and death. Gender (male) and age were independent risk factors, while preoperative ACEI or ARB usage was a protective factor. POAF has not associated the occurrence of MACE with a mid-term follow-up.
References
Amar D, Zhang H, Leung DH, Roistacher N, Kadish AH. 2002. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology. 96(2):352-356.
Calafiore AM, Giammarco GD, Teodori G, et al. 1996. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg. 61(6):1658-1663; discussion 1664-1655.
Clement KC, Alejo D, DiNatale J, et al. 2019. Increased glucose variability is associated with atrial fibrillation after coronary artery bypass. J Card Surg. 34(7):549-554.
Diegeler A, Thiele H, Falk V, et al. 2002. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med. 347(8):561-566.
Dietrich JW, Muller P, Schiedat F, et al. 2015. Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling. Eur Thyroid J. 4(2):129-137.
Farouk Musa A, Quan CZ, Xin LZ, et al. 2018. A retrospective study on atrial fibrillation after coronary artery bypass grafting surgery at The National Heart Institute, Kuala Lumpur. F1000Res. 7:164.
Filardo G, Damiano RJ, Jr., Ailawadi G, et al. 2018. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart. 104(12):985-992.
Jaffery Z, Kowalski M, Weaver WD, Khanal S. 2007. A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg. 31(4):691-697.
January CT, Wann LS, Calkins H, et al. 2019. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 74(1):104-132.
Kievisas M, Keturakis V, Vaitiekunas E, Dambrauskas L, Jankauskiene L, Kinduris S. 2017. Prognostic factors of atrial fibrillation following coronary artery bypass graft surgery. Gen Thorac Cardiovasc Surg. 65(10):566-574.
Lee SH, Lee H, Park JK, et al. 2017. Gender Difference in the Long-Term Clinical Implications of New-Onset Atrial Fibrillation after Coronary Artery Bypass Grafting. Yonsei Med J. 58(6):1119-1127.
Mariscalco G, Klersy C, Zanobini M, et al. 2008. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 118(16):1612-1618.
Piccini JP, Zhao Y, Steinberg BA, et al. 2013. Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery. Am J Cardiol. 112(7):954-960.
Thoren E, Hellgren L, Stahle E. 2016. High incidence of atrial fibrillation after coronary surgery. Interact Cardiovasc Thorac Surg. 22(2):176-180.
Vidotti E, Vidotti LFK, Arruda Tavares CAG, et al. 2019. Predicting postoperative atrial fibrillation after myocardial revascularization without cardiopulmonary bypass: A retrospective cohort study. J Card Surg. 34(7):577-582.
Zheng Z, Jayaram R, Jiang L, et al. 2016. Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med. 374(18):1744-1753.
